Global Patent Index - EP 2408778 A1

EP 2408778 A1 20120125 - N-[(6-AZA-BICYCLO[3.2.1]OCT-5-YL)-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME

Title (en)

N-[(6-AZA-BICYCLO[3.2.1]OCT-5-YL)-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME

Title (de)

N-[(6-AZABICYCLO[3.2.1]OCT-5-YL]ARYLMETHYL] HETEROBENZAMIDDERIVATE, DEREN HERSTELLUNG UND DEREN THERAPEUTISCHE VERWENDUNG

Title (fr)

DERIVES DE N-[(6-AZA-BICYCLO[3.2.1]OCT-5-YL)-ARYL-METHYL]-HETEROBENZAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publication

EP 2408778 A1 20120125 (FR)

Application

EP 10715933 A 20100315

Priority

  • FR 2010050448 W 20100315
  • FR 0901220 A 20090316

Abstract (en)

[origin: WO2010106270A1] The invention relates to a compound of the general formula (I), where: R is a hydrogen atom or a group selected from the (C1-C6)alkyl or (C3-C7)-cycloalkyl groups, optionally substituted by one or more groups independently selected from a halogen atom and the (C3-C7)-cycloalkyl, (C1-C6)alkyl, (C1-C6)alkoxy, and hydroxy groups; R1 is a phenyl group optionally substituted by one or more substituents independently selected from halogen atoms and the (C1- C6)alkyl, (C1-C6)alkoxy, halo-(C1C6)alkyl, hydroxy, halo-(C1-C6)alkoxy, (C1-C6)alkyl-thio, (C1-C6)alkyl-SO, and (C1-C6)alkyl-SO2 groups; R2 is one or more substituents selected from a hydrogen atom, halogen atoms, and the halo-(C1-C6)alkyl, (C1-C6)alkyl, (C3-C7)cycloalkyl, (C3-C7)-cycloalkyl-(C1C3)alkyl, phenyl, benzyl, (C1-C6)alkoxy, (C1-C6)alkyl-thio, (C1-C6))alkyl-SO, and (C1-C6)alkyl-SO2 groups; and Het is a heteroaryl group; wherein said compound is in the form of a base or an acid addition salt. The invention also relates to the therapeutic use thereof and to a method for synthesising same.

IPC 8 full level

C07D 487/08 (2006.01); A61K 31/403 (2006.01); A61K 31/55 (2006.01); A61P 25/00 (2006.01)

CPC (source: EP KR US)

A61P 15/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/32 (2017.12 - EP); C07D 487/08 (2013.01 - EP KR US)

Citation (search report)

See references of WO 2010106270A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DOCDB simple family (publication)

FR 2943059 A1 20100917; AR 075838 A1 20110427; AU 2010224721 A1 20111006; BR PI1009497 A2 20180313; CA 2755528 A1 20100923; CN 102356084 A 20120215; EP 2408778 A1 20120125; IL 215103 A0 20111229; JP 2012520346 A 20120906; KR 20120013325 A 20120214; MX 2011009746 A 20110929; RU 2011141760 A 20130427; SG 174432 A1 20111028; TW 201100431 A 20110101; US 2012029027 A1 20120202; UY 32496 A 20101029; WO 2010106270 A1 20100923

DOCDB simple family (application)

FR 0901220 A 20090316; AR P100100801 A 20100315; AU 2010224721 A 20100315; BR PI1009497 A 20100315; CA 2755528 A 20100315; CN 201080012152 A 20100315; EP 10715933 A 20100315; FR 2010050448 W 20100315; IL 21510311 A 20110912; JP 2012500293 A 20100315; KR 20117024140 A 20100315; MX 2011009746 A 20100315; RU 2011141760 A 20100315; SG 2011066842 A 20100315; TW 99107513 A 20100315; US 201013256834 A 20100315; UY 32496 A 20100316